Howland Capital Management’s AstraZeneca AZN Stock Holding History

Howland Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$556K	Sell	2,930 -70	-2%	-$13.2K	0.02%	200
2026 Q1	$592K	Buy	+3,000	New	+$578K	0.02%	187
2025 Q4	–	Sell	-3,500	Closed	-$537K	–	272
2025 Q3	$537K	Sell	3,500 -23	-0.7%	-$3.48K	0.02%	198
2025 Q2	$492K	Buy	3,523 +23	+0.7%	+$3.22K	0.02%	202
2025 Q1	$515K	Sell	3,500 -954	-21%	-$138K	0.02%	192
2024 Q4	$584K	Buy	4,454 +47	+1%	+$6.58K	0.03%	191
2024 Q3	$687K	Sell	4,407 -388	-8%	-$62.6K	0.03%	181
2024 Q2	$748K	Sell	4,795 -842	-15%	-$127K	0.04%	159
2024 Q1	$764K	Sell	5,637 -17	-0.3%	-$2.25K	0.04%	154
2023 Q4	$762K	Sell	5,654 -250	-4%	-$32.5K	0.04%	152
2023 Q3	$800K	Hold	5,904	–	–	0.05%	141
2023 Q2	$845K	Sell	5,904 -956	-14%	-$141K	0.05%	138
2023 Q1	$952K	Sell	6,860 -423	-6%	-$56.9K	0.06%	129
2022 Q4	$988K	Hold	7,283	–	–	0.06%	127
2022 Q3	$799K	Sell	7,283 -14	-0.2%	-$1.78K	0.05%	133
2022 Q2	$964K	Sell	7,297 -500	-6%	-$65.6K	0.06%	123
2022 Q1	$1.03M	Sell	7,797 -241	-3%	-$28.9K	0.06%	108
2021 Q4	$936K	Buy	8,038 +54	+0.7%	+$6.35K	0.05%	115
2021 Q3	$959K	Sell	7,984 -477	-6%	-$55.5K	0.05%	121
2021 Q2	$1.01M	Hold	8,461	–	–	0.05%	120
2021 Q1	$841K	Hold	8,461	–	–	0.05%	129
2020 Q4	$846K	Sell	8,461 -455	-5%	-$48.2K	0.05%	122
2020 Q3	$977K	Sell	8,916 -12	-0.1%	-$1.33K	0.06%	109
2020 Q2	$944K	Sell	8,928 -589	-6%	-$60.8K	0.07%	110
2020 Q1	$850K	Sell	9,517 -317	-3%	-$29.8K	0.07%	107
2019 Q4	$981K	Sell	9,834 -795	-7%	-$74.8K	0.07%	115
2019 Q3	$947K	Buy	10,629 +861	+9%	+$74.7K	0.07%	115
2019 Q2	$806K	Hold	9,768	–	–	0.06%	121
2019 Q1	$790K	Hold	9,768	–	–	0.06%	121
2018 Q4	$742K	Sell	9,768 -2,000	-17%	-$156K	0.07%	114
2018 Q3	$931K	Buy	11,768 +1,768	+18%	+$134K	0.07%	124
2018 Q2	$702K	Sell	10,000 -1,000	-9%	-$71.9K	0.06%	139
2018 Q1	$769K	Hold	11,000	–	–	0.06%	130
2017 Q4	$763K	Hold	11,000	–	–	0.06%	137
2017 Q3	$745K	Hold	11,000	–	–	0.06%	135
2017 Q2	$750K	Sell	11,000 -20,500	-65%	-$1.34M	0.06%	132
2017 Q1	$1.96M	Sell	31,500 -6,712	-18%	-$391K	0.17%	88
2016 Q4	$2.09M	Buy	38,212 +9,369	+32%	+$532K	0.19%	84
2016 Q3	$1.9M	Sell	28,843 -2,657	-8%	-$174K	0.18%	82
2016 Q2	$1.9M	Hold	31,500	–	–	0.18%	83
2016 Q1	$1.77M	Hold	31,500	–	–	0.18%	82
2015 Q4	$2.14M	Sell	31,500 -1,350	-4%	-$88.5K	0.22%	82
2015 Q3	$2.09M	Hold	32,850	–	–	0.23%	80
2015 Q2	$2.09M	Buy	32,850 +11,907	+57%	+$815K	0.21%	85
2015 Q1	$1.43M	Buy	20,943 +1,248	+6%	+$86.7K	0.15%	98
2014 Q4	$1.39M	Hold	19,695	–	–	0.14%	101
2014 Q3	$1.41M	Hold	19,695	–	–	0.14%	96
2014 Q2	$1.46M	Sell	19,695 -206	-1%	-$14.9K	0.15%	94
2014 Q1	$1.29M	Hold	19,901	–	–	0.15%	98
2013 Q4	$1.18M	Sell	19,901 -12,284	-38%	-$667K	0.15%	99
2013 Q3	$1.67M	Buy	32,185 +12,284	+62%	+$617K	0.23%	85
2013 Q2	$941K	Buy	+19,901	New	+$1.01M	0.15%	89

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Howland Capital Management's AZN Position: Q2 2026 in Review

Howland Capital Management reduced its AstraZeneca (AZN) stake by 2.3% in Q2 2026, selling an estimated $13.2K and leaving 2,930 shares worth $556K. The position accounts for 0.02% of the portfolio, ranked #200.

Howland Capital Management first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.14M in Q4 2015. 269 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Howland Capital Management held 2,930 shares of AstraZeneca worth $556K as of Q2 2026.
Howland Capital Management sold 70 AstraZeneca shares in Q2 2026, an estimated $13.2K.
AstraZeneca made up 0.02% of Howland Capital Management's portfolio in Q2 2026, its #200 holding.
Howland Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
Howland Capital Management's AstraZeneca position peaked at $2.14M in Q4 2015.
269 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.